Thus, to test whether TRIP12 inhibition will sensitize other cancer cells to Taxol, we knockdown TRIP12 in ovarian cancer cells and treated those cells with increasing doses of Taxol. This evidence concerns the gene TRIP12 and ovarian cancer.